Oyster Point Pharma to be Acquired by Viatris

Oyster Point Pharma, Inc announced that it has entered into a definitive agreement under which Viatris Inc, a global healthcare company, would acquire Oyster Point Pharma, a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ophthalmic diseases. Viatris intends to acquire Oyster...